One of the potential problems with inhibiting the PI3K/Akt/mTOR pathway is that the pathway remains an important part of healthy cell metabolism, and as elucidated previously, inhibition of this pathway in healthy cells can lead to decreased insulin sensitivity and potentially T2D [108]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.